Skip Navigation
Skip to contents

KSC 2018

KSC 2020 : 대한심장학회 제64차 추계학술대회
10.11 Thu. - 13 Sat. / Grand Walkerhill Seoul, Korea

Scientific Program

Home > Program > Scientific Program
08:40-10:10
 Cardiometabolic Syndrome Update in SGLT2 Inhibitors from Cardiometabolic Perspective Channel 01
Chairpersons Sang-Hyun Kim, Seung Hwan Han
Panel Se Eun Park, Chan Joo Lee
08:40 - 09:00
HFpEF Malady, Model, Mechanism [Speaker] Joseph A. Hill/UT Southwestern Medical Center,USA
09:00 - 09:20
SGLT2 Inhibitors Are Heart Failure Drug [Speaker] Jin Joo Park/Seoul National Univ.,Korea
09:20 - 09:40
No, SGLT2 Inhibitors Are Antidiabetic Medication [Speaker] Jun Hwa Hong/Eulji Univ.,Korea
09:40 - 10:00
Side Effect in SGLT2 Inhibitor [Speaker] Sang Man Jin/Sungkyunkwan Univ.,Korea
10:00 - 10:10
Discussion
Heart Failure 1 HF Debate I: Hot Issues in Cardiac Critical Care Channel 02
Chairpersons Myeong-Chan Cho, Myung A Kim
Panel Kye Hun Kim, Sang Min Park, Jae Hyung Park, Kyung-Kuk Hwang, Seok-Jae Hwang
08:40 - 08:52
Pro: Swan-Ganz Catheter in Cardiac Critical Care: It Should Be Done in Some Cases [Speaker] Jeong Hoon Yang/Sungkyunkwan Univ.,Korea
08:52 - 09:04
Con: Echocardiographic Hemodynamic Monitoring Is Enough [Speaker] Mi-Na Kim/Korea Univ.,Korea
09:04 - 09:09
Pro Rebuttal [Speaker] Jeong Hoon Yang/Sungkyunkwan Univ.,Korea
09:09 - 09:14
Con Rebuttal [Speaker] Mi-Na Kim/Korea Univ.,Korea
09:14 - 09:25
Discussion
09:25 - 09:37
Pro: Awake ECMO, Pros [Speaker] Soo Yong Lee/Pusan National Univ.,Korea
09:37 - 09:49
Con: Awake ECMO, Cons [Speaker] Seon Gi Lee/Hallym Univ.,Korea
09:49 - 09:54
Pro Rebuttal [Speaker] Soo Yong Lee/Pusan National Univ.,Korea
09:54 - 09:59
Con Rebuttal [Speaker] Seon Gi Lee/Hallym Univ.,Korea
09:59 - 10:10
Discussion
 Myocardial Infarction 1 Joint Collaboration for Asian AMI Guideline Channel 03
Chairpersons Satoshi Yasuda, Myung Ho Jeong
Panel Ung Kim, Youngkeun Ahn, Young-Hoon Jeong, Joo-Yong Hahn
08:40 - 09:00
Antithrombotic Therapy in Atrial Fibrillation Patients with Coronary Artery Disease: Shifting Paradigm to a “Less Is More” Concept Regimen [Speaker] Satoshi Yasuda/National Cerebral and Cardiovascular Center,Japan
09:00 - 09:20
ECMO Application in AMI Patients Complicated with Cardiac Arrest [Speaker] Bin Liu/Jilin Univ.,China
09:20 - 09:40
Identifying Gaps in AMI Care [Speaker] Yeo Khung Keong/National Heart Centre,Singapore
09:40 - 10:00
Consensus Document for Korean AMI [Speaker] Kiyuk Chang/Catholic Univ.,Korea
10:00 - 10:10
Discussion
 Basic Research Hotline Issues in Cardiovascular Diseases Channel 04
Chairpersons Jin Han, Yin Hua Zhang
Panel Ki-Hwan Kwon, Jang-Whan Bae, Woo Cheol Chang
08:40 - 08:55
New Insights on Diabetic Cardiomyopathy [Speaker] Barbara Casadei/Univ. of Oxford,UK
08:55 - 09:10
Molecular Mechanism of Obesity-induced Hypertension [Speaker] Young-Myeong Kim/Kangwon National Univ.,Korea
09:10 - 09:25
Altered Shear Stress Response in Atrial Myocytes from Failed Heart [Speaker] Sun Hee Woo/Chungnam National Univ.,Korea
09:25 - 09:40
Inter-mitochondrial Communication and the Pathophysiological Relevance in the Heart [Speaker] Ming Zheng/Peking Univ.,China
09:40 - 10:10
Discussion
10:20-11:50
Cross Specialty: Gastroenterology & Intervention Channel 01
Chairpersons Hyeon-Cheol Gwon, Doo Il Kim
Panel Bon-Kwon Koo, Ki-Hwan Kwon
1. Skip or Continue Antiplatelet Therapy before Endoscopic Procedure
10:20 - 10:35
Why Cardiologists Are Uncomfortable to Skip Antiplatelet Therapy?, and My Solution [Speaker] Young-Hoon Jeong/Gyeongsang National Univ.,Korea
10:35 - 10:50
Why Endoscopists Are Uncomfortable to Continue Antiplatelet Therapy?, and My Solution [Speaker] Jun Haeng Lee/Sungkyunkwan Univ.,Korea
10:50 - 11:05
Discussion
2. Cardiovascular Drug Induced Hepatitis
11:05 - 11:20
Cardiovascular Drugs Which Requires Attention for Hepatic Dysfunction [Speaker] Kyungil Park/Dong-A Univ.,Korea
11:20 - 11:35
Why You Have to Stop Cardiovascular Drugs Due to Hepatic Dysfunction and How to Restart? [Speaker] Dong Joon Kim/Hallym Univ.,Korea
11:35 - 11:50
Discussion
Es Heart Failure 2 HF 2020 at a Glance Channel 02
Chairpersons Kyu Hyung Ryu, Dong Ju Choi
Panel Sung Hae Kim, Eung Ju Kim, Dae Gyun Park, Seonghoon Choi, Eui-Young Choi, Jin Oh Choi
10:20 - 10:35
Updates in HFrEF Treatment: From SOLVD to VICTORIA [Speaker] Jong-Chan Youn/Catholic Univ.,Korea
10:35 - 10:45
HFrEF Designated Discussion [Speaker] Byung Su Yoo/Yonsei Wonju Univ.,Korea
10:45 - 11:00
Never Ending Story of Failure: HFpEF Treatment [Speaker] Jin Joo Park/Seoul National Univ.,Korea
11:00 - 11:10
HFpEF Designated Discussion [Speaker] Sung Ji Park/Sungkyunkwan Univ.,Korea
11:10 - 11:25
ICD/CRT in HF: Something You May Not Know, but Should Know [Speaker] Sang Eun Lee/Ulsan Univ.,Korea
11:25 - 11:35
ICD/CRT Designated Discussion [Speaker] Seung Jung Park/Sungkyunkwan Univ.,Korea
11:35 - 11:50
Discussion
Imaging Coronary Plaque Imaging Channel 03
Chairpersons Yeon Hyeon Choe, Jae-Kwan Song
Panel Won Jun Kang, Dong Hyun Yang, Ju-Hee Lee, Sang Il Choi
10:20 - 10:40
Coronary Plaque Imaging: Why Should We Do? [Speaker] Cheol Whan Lee/Ulsan Univ.,Korea
10:40 - 11:00
Coronary Plaque: Invasive Imaging [Speaker] Soo-Jin Kang/Ulsan Univ.,Korea
11:00 - 11:20
Coronary Plaque: CT Imaging [Speaker] Sang Eun Lee/Ewha Univ.,Korea
11:20 - 11:40
Coronary Plaque: Nuclear Imaging [Speaker] Sang-Geon Cho/Chonnam National Univ.,Korea
11:40 - 11:50
Discussion
Arrhythmia 1 AF Screening and Stroke Prevention Channel 04
Chairpersons June Soo Kim, Kee-Joon Choi, Dae Kyeong Kim
Panel Minsoo Kim, Ji Eun Ban, Myung Hwan Bae
10:20 - 10:30
The Trend and Burden of Korean AF [Speaker] Pil-Sung Yang/Cha Univ.,Korea
10:30 - 10:40
Risk Stratification of Thromboembolism [Speaker] Kwang No Lee/Ajou Univ.,Korea
10:40 - 10:50
Imaging Modalities for AF Treatment [Speaker] Jung Myung Lee/Kyunghee Univ.,Korea
10:50 - 11:00
Korean Practical Guideline of NOAC Use [Speaker] Jin-Kyu Park/Hanyang Univ.,Korea
11:00 - 11:10
Selection of NOAC [Speaker] So-Ryoung Lee/Seoul National Univ.,Korea
11:10 - 11:20
Wearable Monitoring and Opportunistic Screening of AF: State of the Art [Speaker] Yong Soo Baek/Inha Univ.,Korea
11:20 - 11:30
How to Apply Korean Anticoagulation Guideline in PCI Patients [Speaker] Yu Mi Hwang/Catholic Univ.,Korea
11:30 - 11:40
Non-genetic Risk Factor for AF [Speaker] Yun Gi Kim/Korea Univ.,Korea
11:40 - 11:50
Discussion
12:00-13:30
Scientific Session [Pfizer Upjohn] Evidence Based Strategies: Optimizing an ASCVD Management Channel 01
Chairpersons Kyoo Rok Han, Yong-Jin Kim
12:00 - 12:20
Highlighting Atorvastatin`s CV Protection Evidence in the Last Few Decades [Speaker] Jun-Hee Lee/Hallym Univ.,Korea
12:20 - 12:40
Amlodipine, 30 Years of Evidence in Hypertension Treatment: Now from Children to Adults [Speaker] Il Suk Sohn/Kyunghee Univ.,Korea
Scientific Session [Amgen] The Earlier, The Better: An Ideal Approach with PCSK9 Inhibition in ACS Patients Channel 02
Chairpersons Myung Ho Jeong, Hyo-Soo Kim
12:00 - 12:15
The Importance of LDL-C Lowering with Evolocumab in Recent ACS [Speaker] Jung-Won Suh/Seoul National Univ.,Korea
12:15 - 12:30
PCSK9 Inhibition: Beyond LDL-C Lowering Effect in ACS Patients [Speaker] Young-Hoon Jeong/Gyeongsang National Univ.,Korea
12:30 - 12:40
Discussion
Scientific Session [Boryung] What`s New in Cardiovascular Disease Risk Management Channel 03
Chairpersons Man Young Lee, Seok Min Kang
12:00 - 12:20
Facing the Challenge of Hypertension and Dyslipidemia Management [Speaker] Jinho Shin/Hanyang Univ.,Korea
12:20 - 12:40
Outcomes after Use of 110mg Dabigatran in Patients with AF [Speaker] Woo Hyun Lim/Seoul National Univ.,Korea
Diamond Session [BMS/Pfizer] Anticoagulation Management in NVAF: Optimizing Patient Outcomes Channel 04
Chairpersons Dae Hyeok Kim, Boyoung Joung
12:00 - 12:20
The Evolution of the ESC Atrial Fibrillation Management Guideline [Speaker] Seung Yong Shin/Chung-Ang Univ.,Korea
12:20 - 12:40
Long-term Persistence and Adherence in Patients with Atrial Fibrillation: Impact of Dosing Frequency [Speaker] Seung Jung Park/Sungkyunkwan Univ.,Korea
Lipid Management of Dyslipidemia in Diverse Diseases Channel 05
Chairpersons Chee Jeong Kim, In Kyung Jeong
Panel Hack-Lyoung Kim, Hun-Jun Park, Won Woo Seo, Hyo-Suk Ahn, Junhwan Cho
12:00 - 12:20
Dyslipidemia Management in Diabetes [Speaker] In Kyung Jeong/Kyunghee Univ.,Korea
12:20 - 12:40
Dyslipidemia Management in Stroke [Speaker] Wi-Sun Ryu/Dongguk Univ.,Korea
12:40 - 13:00
Dyslipidemia Management in Kidney Disease [Speaker] Kyu-Beck Lee/Sungkyunkwan Univ.,Korea
13:00 - 13:20
Dyslipidemia Management in Coronary Artery Disease [Speaker] Sang-Ho Jo/Hallym Univ.,Korea
13:20 - 13:30
Discussion
14:00-15:30
Myocardial Infarction 2 Recent Updates in AMI Channel 01
Chairpersons Hyo-Soo Kim, Kwang Soo Cha
Panel Jae Youn Moon, Jon Suh, Jang Hoon Lee, Jung-Hee Lee, Jin Yong Hwang
14:00 - 14:20
Impact of Recent AMI Trials on My Daily Practice: COMPLETE, ISAR-REACT 5, CULPRIT SHOCK, COAPT [Speaker] Sang Yeub Lee/Chungbuk National Univ.,Korea
14:20 - 14:40
PCI for Nonculprit Lesion in STEMI: Assessment, Timing and Outcome [Speaker] Jin Shin Koh/Gyeongsang National Univ.,Korea
14:40 - 15:00
How to Improve Suboptimal Reperfusion in STEMI? [Speaker] Eun Ho Chu/Catholic Univ.,Korea
15:00 - 15:20
Challenges in Reperfusion for STEMI in the COVID-19 Pandemics [Speaker] Jeongsu Kim/Pusan National Univ.,Korea
15:20 - 15:30
Discussion
Cross Specialty: Arrhythmia & Heart Failure Clinical Challenges: AF and HF Channel 02
Chairpersons Dong Ju Choi, Yong Seog Oh
14:00 - 14:10
Introduction- Incidence Epidemiology Risk [Speaker] Pil-Sung Yang/Cha Univ.,Korea
14:10 - 14:20
AF Causing HF Versus HF Causing AF: Can We Tell One from the Other [Speaker] Eung Ju Kim/Korea Univ.,Korea
14:20 - 14:30
Optimal Management of the Patients with AF and HF: Anticoagulation and Antiarrhythmic Drugs [Speaker] Jong-Il Choi/Korea Univ.,Korea
14:30 - 14:40
Optimal Management of the Patients with AF and HF: Beta-blocker Still Useful? [Speaker] Jin Joo Park/Seoul National Univ.,Korea
14:40 - 14:50
Role of AF Ablation in HF - AF Ablation vs. AV Node Ablation and CRT as Primary Therapy [Speaker] Hyoung-Seob Park/Keimyung Univ.,Korea
14:50 - 15:00
AF in HF: Ablate or Not? [Speaker] Sang Eun Lee/Ulsan Univ.,Korea
15:00 - 15:30
Discussion
Es Echocardiography 1 Mitral Regurgitation: From Diagnosis to Treatment Channel 03
Chairpersons Jun Kwan, Jong-Won Ha
Panel Hyung Yoon Kim, Il Suk Sohn, Wook-Jin Chung, Eui-Young Choi
14:00 - 14:20
Comprehensive Analysis of Mitral Regurgitation Using TTE, TEE and 3D Echocardiography [Speaker] Iksung Cho/Yonsei Univ.,Korea
14:20 - 14:40
Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework from Mitraclip Trials [Speaker] Sung Ji Park/Sungkyunkwan Univ.,Korea
14:40 - 15:00
Echocardiographic Evaluation and Procedure Monitoring in Percutaneous Mitral Intervention [Speaker] Dae-Hee Kim/Ulsan Univ.,Korea
15:00 - 15:20
Surgical Mitral Valve Repair: Where We Stand? [Speaker] Jae Suk Yoo/Sejong Hospital,Korea
15:20 - 15:30
Discussion
Cardiac Surgery In the Era of MCS, Are We Transplanting the Heart More to Moribund Patients? Channel 04
Chairpersons Ji-Hyuk Yang, Sung Ho Jung
Panel Jun Kyu Kang, Jun Sung Kim, Jae Jin Lee
14:00 - 14:15
Selection Criteria for Candidates and Current Status of Heart Transplant in Korea [Speaker] Sun Young Kim/KONOS,Korea
14:15 - 14:30
Heart Transplant with or without MCS: Trends in Korea [Speaker] Yang Hyun Cho/Sungkyunkwan Univ.,Korea
14:30 - 14:45
Factors Affecting the Long-term Outcome of Heart Transplant in the Era of MCS [Speaker] Ho Young Hwang/Seoul National Univ.,Korea
14:45 - 15:00
How Can We Overcome the Shortage of Donors? [Speaker] Jae-Seung Jung/Korea Univ.,Korea
15:00 - 15:30
Discussion
15:40-17:10
Women Heart Disease Immunity and Heart Channel 01
Chairpersons Myung A Kim, Kyung-Soon Hong
Panel In Cheol Kim, Jang-Young Kim, Seong-Mi Park, Jin-Ok Jeong
15:40 - 16:00
Immune and Heart [Speaker] Hack-Lyoung Kim/Seoul National Univ.,Korea
16:00 - 16:20
Autoimmune Related Cardiac Disease [Speaker] Mi-Na Kim/Korea Univ.,Korea
16:20 - 16:40
Viral Infection and Heart [Speaker] Young Sup Byun/Inje Univ.,Korea
16:40 - 17:00
Vaccination and Heart [Speaker] Hyung Yoon Kim/Chonnam National Univ.,Korea
17:00 - 17:10
Discussion
New Frontiers in Cardiology 1: Heart Failure Heart Failure 2020 Channel 02
Chairpersons Kee Sik Kim, Dong Ju Choi
Panel Min-Seok Kim, Jong-Chan Youn, Seonghoon Choi, Jin Oh Choi
15:40 - 16:00
HF Epidemiology, Awareness and Performance Measures [Speaker] Byung Su Yoo/Yonsei Wonju Univ.,Korea
16:00 - 16:20
Update on Recent HF Guidelines [Speaker] Hyun-Jai Cho/Seoul National Univ.,Korea
16:20 - 16:40
Surgical Treatment of Advanced HF: HTx and LVAD [Speaker] Sung Ho Jung/Ulsan Univ.,Korea
16:40 - 17:10
Discussion
 JCS-KSC Joint Session: Cardiometabolic Syndrome SGLT2 Inhibitor vs. GLP1 Analogue for Cardiometabolic Syndrome Channel 03
Chairpersons Motoaki Sano, Soo Lim
Panel Sang Hyun Ihm
15:40 - 16:00
Selective Roles of SGLT2 Inhibitors and GLP-1 Analogues to Reduce Cardiovascular Risk [Speaker] In Chang Hwang/Seoul National Univ.,Korea
16:00 - 16:20
Efficacy and Mechanism of Action of SGLT2 Inhibitors in Heart Failure [Speaker] Motoaki Sano/Keio Univ.,Japan
16:20 - 16:40
Novel Duo for Cardiometabolic Syndrome: SGLT2 Inhibitors and GLP-1 [Speaker] Jun Sung Moon/Youngnam Univ.,Korea
16:40 - 17:00
Natriuretic Effect of SGLT2 and Its Mechanisms in Patients with HF and T2DM [Speaker] Kaoru Dohi/Mie Univ.,Japan
17:00 - 17:10
Discussion
 Cardiac Pathology Cardiac Conduction System in Human Heart Channel 04
Chairpersons June Huh, Seil Oh
Panel Jin-Seok Kim, Jeong Wook Seo, Mi Kyoung Song, Jae-Sun Uhm, Hee Tae Yu, Won-Seok Choi
15:40 - 16:00
Embryology of Conduction System [Speaker] Jung Sun Kim/Sungkyunkwan Univ.,Korea
16:00 - 16:20
His-purkinje System [Speaker] Il-Young Oh/Seoul National Univ.,Korea
16:20 - 16:40
Cardiac Conduction System for Electrophysiologist [Speaker] S Yen Ho/Royal Brompton Hospital,UK
16:40 - 17:00
Cardiac Conduction System in Congenital Heart Disease [Speaker] S Yen Ho/Royal Brompton Hospital,UK
17:00 - 17:10
Discussion
17:20-18:50
Epidemiology 국민건강보험빅데이터(NHI-BD)를 이용한 심혈관질환 역학연구 Channel 01
Chairpersons Dong Wook Kim, Hae-Young Lee
Panel Hun-Sung Kim, Ki Chul Sung, Hokyou Lee
17:20 - 17:40
고혈압 및 심혈관질환 역학연구 [Speaker] Hyeon Chang Kim/Yonsei Univ.,Korea
17:40 - 18:00
당뇨병 및 심혈관질환 역학연구 [Speaker] Sang Youl Rhee/Kyunghee Univ.,Korea
18:00 - 18:20
심혈관계 약물의 비교효과 연구 [Speaker] Seung Chan Yoo/Ajou Univ.,Korea
18:20 - 18:40
만성질환 질병 부담 평가 연구 [Speaker] Min Woo Jo/Ulsan Univ.,Korea
18:40 - 18:50
Discussion
Nurse-Technician Session Changes in the Environment of Cath Rooms Channel 02
Chairpersons Min Suk Lee, Eun-Shim Park
Panel Joon Won Kang, Tae Woo Kim, Kyung Jin Park, Sung Il Baek, Kyu Sung Lee, Seung Hoon Lee, Hyun Jin Lee
17:20 - 17:40
Recent Trends in Cathroom Configuration (Hardware Setup) [Speaker] Ha Joon Lee/Korea Univ.,Korea
17:40 - 18:00
Introducing the Latest Device Updates [Speaker] Seung Hyun Lee/Yonsei Univ.,Korea
18:00 - 18:20
PCI Procedure under the Support Ecmo [Speaker] Sang Man Park/Sungkyunkwan Univ.,Korea
18:20 - 18:40
Changes in Cathroom Procedure Environment Due to COVID-19 [Speaker] Sun Bae Kim/Ulsan Univ.,Korea
18:40 - 18:50
Discussion
Smart Health Remote Monitoring of Cardiovascular Diseases Channel 03
Chairpersons Seung Woo Park, Young Hak Kim
Panel Jeong Hoon Yang, Chang-Hwan Yoon, Min Ho Lee
17:20 - 17:35
Remote Monitoring by Implantable Devices [Speaker] Boyoung Joung/Yonsei Univ.,Korea
17:35 - 17:50
Remote Monitoring by Wearable Devices [Speaker] Il-Young Oh/Seoul National Univ.,Korea
17:50 - 18:05
Ubiquitous Blood Pressure Monitoring by New Technologies [Speaker] Jun-Bean Park/Seoul National Univ.,Korea
18:05 - 18:20
Pro and Cons of Telemonitoring of ICU [Speaker] Ki Hyun Jeon/Mediplex Sejong Hospital,Korea
18:20 - 18:50
Discussion
Intervention 1 Which Evidence-Based NOAC Should Be the Preferred Dual Anti-thrombotic Regimen in AF Patients Undergoing PCI? Channel 04
Chairpersons Kyoo Rok Han, Youngkeun Ahn
Panel Woong Chol Kang, Sung Eun Kim, Jung-Sun Kim, Joon Hyung Doh, Young Joon Hong
17:20 - 17:35
P2Y12 Inhibitor with Rivaroxaban [Speaker] Kyung Woo Park/Seoul National Univ.,Korea
17:35 - 17:50
P2Y12 Inhibitor with Dabigatran [Speaker] Suk Min Seo/Catholic Univ.,Korea
17:50 - 18:05
P2Y12 Inhibitor with Apixaban [Speaker] Hong-Seok Lim/Ajou Univ.,Korea
18:05 - 18:20
P2Y12 Inhibitor with Edoxaban [Speaker] Jae Hyung Park/Korea Univ.,Korea
18:20 - 18:50
Discussion